Viral Glycoproteins Group, TPI

This was coming: Mpox has been on the move for a while and there was no reason to believe the 2022 global outbreak was going to be the only one. Stopping #mpox in Africa is a must. Mpox in Africa: New strain declared a continental public health emergency bbc.com/news/articles/…

Super interesting panel discussion at the end of #PandemicSciences24 meeting. Blend of economic, health, regulatory, governmental opinions.

📢 PhD position available in my lab! We are interested in developing host-targeting antivirals against coronaviruses & emerging viruses. Join our multidisciplinary and supportive team, w/ @t_snape. Fully-funded for UK students. Deadline 26 July. findaphd.com/phds/project/d…

Two 3-year Post-Doc positions available in my group in @tcddublin @TrinityMed1 working on poxviral immune evasion of the human Interferon system. Please share with anyone that might be interested. my.corehr.com/pls/trrecruit/… my.corehr.com/pls/trrecruit/…

Just putting this out there again before the closing date, if you know anyone that might be interested in applying, please pass on! #poxvirus #interferon #TCD

Thrilled to share our new paper in @NatureSMB ! We report DS90, a potent #nanobody against #Nipah and #Hendra virus - the product of an incredible national & international collaboration across 🇦🇺🇨🇱🇨🇳🇬🇧. nature.com/articles/s4159… @UQ_SCMB (Free access preprint provided below 👇)

Out Now! Identifying an evolutionary origin for morbilliviruses in bats bit.ly/4lbNP0f #Morbillivirus #Bats #EvolutionaryBiology

Our pLM-designed peptides, when attached to E3 ligases (aka uAbs), enable us to programmably degrade disease targets (think CRISPRi, but for proteins). But what if we want to STABILIZE useful proteins? In @NatureComms, we introduce duAbs! 🌟 📜: nature.com/articles/s4146… 🧬:…

🚨🔔 Delighted to see this piece of work from @CVRinfo now out in @NatureMicrobiol! Indeed, it really reflects what multidisciplinary team effort can be. Guess what? Spike of #SARSCoV2 is not just about antigenicity/immune evasion… doi.org/10.1038/s41564…

Our magnus opus on #coronavirus host range is ready. Seriously hard work from PDRA Giulia Gallo in @vGlycoproteins. Come see how we use algorithmic-led sequence selection to characterise genus-wide phenotypic diversity! Backing that up with @AtomicVirology biorxiv.org/content/10.110…

The Pirbright Institute seeks two Trustee Directors to bring senior strategic-level experience and a commitment to act as an ambassador for the Institute. Help shape the future of The Pirbright Institute ⬇️ ow.ly/OmZW50SYksB

Fantastic news that the UK have announced the rollout of an RSV vaccine programme! gov.uk/government/new…

The International Pandemic Sciences Conference 2024 starts today 🙌 Leading experts from academia, policy & industry are joining us for sessions on: ✅ vaccines   ✅ therapeutics ✅ diagnostics ✅ policy ✅ epidemiology ✅ ethics ✅ pathogen biology #PandemicSciences24

Delighted to be attending the PSI conference again this year. Very important multidisciplinary network.

We're at #ASV2024 and getting our creative juices flowing, drawing our favourite viruses - can you spot the #RSV #inclusionbodies? 😉 Our post-doc Fatoumatta Jobe will be talking about this tomorrow! @AmerSocVirol @Pirbright_Inst

New paper landed from the lab, from our COVID years: royalsocietypublishing.org/doi/10.1098/rs… We show that things (APOE4 genotype, previous infection) that put you at risk of severe COVID19 disease also increase how well the different SARS-CoV-2 variants infect vascular cells... 1/2

Thank you so much for coming down all the way from England, Naz and Giulia, and congratulations on your award, Giulia! Looking forward to all the cool science that you will be putting out. #CSV2024 @vGlycoproteins

Congratulations to our post doc Dr Giulia Gallo for winning an award for her talk at #CSV2024. We're very proud of both Giulia and @The1stNazerick for going out to @CanSocVirol to represent our lab and showcase some of the research we do with their talks and networking!